{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-002790","form_type":"8-K","ticker":"PMCB","cik":"0001157075","company_name":"PharmaCyte Biotech, Inc.","filed_at":"2025-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.655171+00:00","generated_at":"2026-05-23T06:43:59.459685+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"PharmaCyte Biotech annual meeting elects directors, ratifies auditor, approves exec compensation","bullets":["Annual meeting held Apr 24, 2025; quorum of 3,222,988 shares (~46.92%) present.","All five director nominees elected: Silverman, Schechter, Abecassis, Weinstein, Walker.","CBIZ CPAs P.C. ratified as auditor for FY ending Apr 30, 2025 (for: 3,123,042; against: 72,371).","Non-binding advisory vote approved executive compensation (for: 1,094,399; against: 113,815; abstain: 21,543)."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-002790","json":"https://secwatch.observer/filing/0001683168-25-002790.json","markdown":"https://secwatch.observer/filing/0001683168-25-002790.md","text":"https://secwatch.observer/filing/0001683168-25-002790.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825002790/0001683168-25-002790-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825002790/pharmacyte_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T06:43:59.459685+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}